WCLC 2025 - Posters & ePosters-P3.18.87 EVEREST-2: Phase 1/2 Study of Logic-Gated Tmod CAR T A2B694 in Lung Cancer and Other Tumors Expressing MSLN With HLA-A*02 LOH

P3.18.87 EVEREST-2: Phase 1/2 Study of Logic-Gated Tmod CAR T A2B694 in Lung Cancer and Other Tumors Expressing MSLN With HLA-A*02 LOH

Asset Subtitle

Salman Punekar

Meta Tag

Speaker Salman Punekar

Topic Clinical Trials in Progress